Matthew Koscielski MD in South Bend, Indiana

Home Indiana South Bend

Matthew Koscielski MD has Critical Care (intensivists) as his primary medical specialty. Their primary office is: 621 Memorial Dr in South Bend, Indiana.

They're a part of the: Beacon Medical Group Inc medical group which has around 465 members. You can call their office at 574-246-9350 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Indiana University School Of Medicine and graduated in 1989 (around 35 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Matthew F Koscielski MD Office Phone and Directions

Matthew Koscielski MD
Beacon Medical Group Inc
621 Memorial Dr
South Bend, Indiana 46601
574-246-9350

Patient Ratings
Please rate your experience with Matthew Koscielski MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 574-246-9350

Enter a starting address:

Healthcare Info for Matthew Koscielski MD

Additional Medical Specialties Include:
INTERNAL MEDICINE, PULMONARY DISEASE

Medical School: Indiana University School Of Medicine
Graduation Year: 1989
The Primary Medical Specialty for Matthew Koscielski MD is listed as: Critical Care (intensivists)
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 35
PAC (PECOS ID)#: 2567376445
NPI #: 1629052543
NPI Created On: 12/05/2005
NPI Last Updated Listed as: 04/28/2023
Primary Taxonomy Code: 207RP1001X
License Number:
01038686A
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Celtic Insurance Company
Humana
CareSource
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Examination of lung airways using an endoscope
Irrigation and suction of lung airways to obtain cells using an endoscope
Insertion of central venous catheter for infusion, patient 5 years or older
Insertion of arterial catheter for blood sampling or infusion, accessed through the skin
Vaccine for influenza for administration into muscle, 0.5 ml dosage
Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
Test for exercise-induced lung stress
Determination of lung volumes using plethysmography
Determination of lung volumes using plethysmography
Measurement of lung diffusing capacity
Measurement of lung diffusing capacity
Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 15 minutes
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

They took part in the Million Hearts Initiative, which was deigned to improve cardiac outcomes.

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $32

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788495677

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiology

Name of Drug #1: OPSUMIT

Open Associated Drug #1: 66215-501-30

Drug or Biological: Drug

Product Category #2: Cardiology

Name Of Drug #2:: UPTRAVI

Associated Drug #2: 66215-602-14

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788495675

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788495673

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795150221

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: AVYCAZ

Open Associated Drug #1: 0456-2700-10

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795150225

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: AVYCAZ

Open Associated Drug #1: 0456-2700-10

Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801720629

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $1,200

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 801722201

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801722599

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $115

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Travel and Lodging City: Fort Wayne

Travel and Lodging State: IN

Travel and Lodging Country: United States

Third party is a Charity:: No

Record ID:: 801930421

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $3,600

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 802026369

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Critical Care (intensivists) Professionals in South Bend

1.
Charbel Maskiny

621 Memorial Dr
South-bend, IN
Beacon Medical Group Inc

Providers in Beacon Medical Group Inc

1.Daniel Abel

4630 Vistula Rd
Mishawaka In 46544-4000
Beacon Medical Group Inc
Family Practice

2.Jonathan Abiera

1020 High Rd
Bremen In 46506-1093
Beacon Medical Group Inc
Podiatry

3.Jonathan Abiera

6901 N Main St
Granger In 46530-8022
Beacon Medical Group Inc
Podiatry

4.Hani Ahmad Md

707 N Michigan St
South Bend In 46601-1071
Beacon Medical Group Inc
Psychiatry

5.Rocio Ahuja

1215 Lawn Ave
Elkhart In 46514-2450
Beacon Medical Group Inc
Obstetrics/gynecology

6.Ismail Al-ani Md

621 Memorial Dr
South Bend In 46601-1075
Beacon Medical Group Inc
Pulmonary Disease

View all 465 members of Beacon Medical Group Inc medical group